260 related articles for article (PubMed ID: 33921897)
21. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.
Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI
Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371
[TBL] [Abstract][Full Text] [Related]
22. Piperine impairs cell cycle progression and causes reactive oxygen species-dependent apoptosis in rectal cancer cells.
Yaffe PB; Doucette CD; Walsh M; Hoskin DW
Exp Mol Pathol; 2013 Feb; 94(1):109-14. PubMed ID: 23063564
[TBL] [Abstract][Full Text] [Related]
23. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N; Kumar A
Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
[TBL] [Abstract][Full Text] [Related]
24. Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway.
Lin Y; Xu J; Liao H; Li L; Pan L
Tumour Biol; 2014 Apr; 35(4):3305-10. PubMed ID: 24272201
[TBL] [Abstract][Full Text] [Related]
25. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
Świerczewska M; Sterzyńska K; Wojtowicz K; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027318
[No Abstract] [Full Text] [Related]
26. Piperine inhibits the growth and motility of triple-negative breast cancer cells.
Greenshields AL; Doucette CD; Sutton KM; Madera L; Annan H; Yaffe PB; Knickle AF; Dong Z; Hoskin DW
Cancer Lett; 2015 Feb; 357(1):129-140. PubMed ID: 25444919
[TBL] [Abstract][Full Text] [Related]
27. Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line.
Sedeky AS; Khalil IA; Hefnawy A; El-Sherbiny IM
Eur J Pharm Sci; 2018 Jun; 118():103-112. PubMed ID: 29597041
[TBL] [Abstract][Full Text] [Related]
28. Antitumor and Apoptosis-inducing Effects of Piperine on Human Melanoma Cells.
Yoo ES; Choo GS; Kim SH; Woo JS; Kim HJ; Park YS; Kim BS; Kim SK; Park BK; Cho SD; Nam JS; Choi CS; Che JH; Jung JY
Anticancer Res; 2019 Apr; 39(4):1883-1892. PubMed ID: 30952729
[TBL] [Abstract][Full Text] [Related]
29. Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation.
Fofaria NM; Kim SH; Srivastava SK
PLoS One; 2014; 9(5):e94298. PubMed ID: 24804719
[TBL] [Abstract][Full Text] [Related]
30. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.
Abdelhamed S; Yokoyama S; Refaat A; Ogura K; Yagita H; Awale S; Saiki I
Anticancer Res; 2014 Apr; 34(4):1893-9. PubMed ID: 24692724
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
32. Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB.
Han SZ; Liu HX; Yang LQ; Cui LD; Xu Y
Biomed Pharmacother; 2017 Dec; 96():1403-1410. PubMed ID: 29169726
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT).
Tiwari A; Modi SJ; Gabhe SY; Kulkarni VM
Bioorg Chem; 2021 May; 110():104776. PubMed ID: 33743225
[TBL] [Abstract][Full Text] [Related]
34. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells.
Do MT; Kim HG; Choi JH; Khanal T; Park BH; Tran TP; Jeong TC; Jeong HG
Food Chem; 2013 Dec; 141(3):2591-9. PubMed ID: 23870999
[TBL] [Abstract][Full Text] [Related]
35. Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells.
Samykutty A; Shetty AV; Dakshinamoorthy G; Bartik MM; Johnson GL; Webb B; Zheng G; Chen A; Kalyanasundaram R; Munirathinam G
PLoS One; 2013; 8(6):e65889. PubMed ID: 23824300
[TBL] [Abstract][Full Text] [Related]
36. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment.
Katiyar SS; Muntimadugu E; Rafeeqi TA; Domb AJ; Khan W
Drug Deliv; 2016 Sep; 23(7):2608-2616. PubMed ID: 26036652
[TBL] [Abstract][Full Text] [Related]
37. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
[TBL] [Abstract][Full Text] [Related]
38. Piperine mediates LPS induced inflammatory and catabolic effects in rat intervertebral disc.
Li Y; Li K; Hu Y; Xu B; Zhao J
Int J Clin Exp Pathol; 2015; 8(6):6203-13. PubMed ID: 26261497
[TBL] [Abstract][Full Text] [Related]
39. Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
Sterzyńska K; Kaźmierczak D; Klejewski A; Świerczewska M; Wojtowicz K; Nowacka M; Brązert J; Nowicki M; Januchowski R
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412536
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
Wojtowicz K; Januchowski R; Nowicki M; Zabel M
Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
